Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101)

BACKGROUND: Camrelizumab has shown promising survival benefits in treatment-naïve advanced non-small cell lung cancer (NSCLC) patients when used in combination with chemotherapy. However, its effectiveness and safety outside the clinical trial setting are largely unknown. Therefore, we conducted NOA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rong, Shi, Meiqi, Ji, Mei, Han, Zhengxiang, Chen, Lingxiang, Liu, Yong, Lu, Kaihua, Liu, Lianke, Chen, Bi, Zhang, Xizhi, Miao, Liyun, Shu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183390/
https://www.ncbi.nlm.nih.gov/pubmed/37197631
http://dx.doi.org/10.21037/tlcr-23-121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183390/
https://www.ncbi.nlm.nih.gov/pubmed/37197631
http://dx.doi.org/10.21037/tlcr-23-121

Ejemplares similares